10-Q Filing
Filing Information
| Form Type | 10-Q |
| Accession Number | 0001185185-12-001581 |
| Period End Date | 20120630 |
| Filing Date | 20120730 |
| Fiscal Year | 2012 |
| Fiscal Period | Q2 |
| XBRL Instance | unxl-20120630.xml |
Filing Contents
This filing contains the following financial statements:
Balance Sheet
43 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Accumulated depreciation (in Dollars) |
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
$2.23M | USD | Point-in-time |
| Accumulated depreciation (in Dollars) |
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
$1.98M | USD | Point-in-time |
| Common stock, par value (in Dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$9.59M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$4.63M | USD | Point-in-time |
| Common stock, par value (in Dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$13.05M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$7.22M | USD | Point-in-time |
| Common stock, shares authorized |
CommonStockSharesAuthorized
|
100.00M | shares | Point-in-time |
| Common stock, shares authorized |
CommonStockSharesAuthorized
|
100.00M | shares | Point-in-time |
| Accounts receivable, net |
AccountsReceivableNetCurrent
|
$47.80K | USD | Point-in-time |
| Accounts receivable, net |
AccountsReceivableNetCurrent
|
$4.55K | USD | Point-in-time |
| Common stock, shares issued |
CommonStockSharesIssued
|
7.14M | shares | Point-in-time |
| Common stock, shares issued |
CommonStockSharesIssued
|
7.14M | shares | Point-in-time |
| Total current assets |
AssetsCurrent
|
$4.68M | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$7.22M | USD | Point-in-time |
| Property and equipment, net of accumulated depreciation of $2,230,224 and $1,977,241, at June 30, 2012 and December 31, 2011, respectively |
PropertyPlantAndEquipmentNet
|
$910.74K | USD | Point-in-time |
| Property and equipment, net of accumulated depreciation of $2,230,224 and $1,977,241, at June 30, 2012 and December 31, 2011, respectively |
PropertyPlantAndEquipmentNet
|
$1.15M | USD | Point-in-time |
| Common stock, shares outstanding |
CommonStockSharesOutstanding
|
7.14M | shares | Point-in-time |
| Common stock, shares outstanding |
CommonStockSharesOutstanding
|
7.14M | shares | Point-in-time |
| Restricted cash |
RestrictedCashAndCashEquivalentsAtCarryingValue
|
$17.44K | USD | Point-in-time |
| Restricted cash |
RestrictedCashAndCashEquivalentsAtCarryingValue
|
$17.44K | USD | Point-in-time |
| Total assets |
Assets
|
$5.61M | USD | Point-in-time |
| Total assets |
Assets
|
$8.39M | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$154.63K | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$87.47K | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$154.63K | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$87.47K | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$154.63K | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$87.47K | USD | Point-in-time |
| Commitments and contingencies (Note 3) |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Commitments and contingencies (Note 3) |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Common stock, $0.001 par value; 100,000,000 shares authorized, 7,142,307 shares issued and outstanding at June 30, 2012 and December 31, 2011 |
CommonStockValue
|
$7.14K | USD | Point-in-time |
| Common stock, $0.001 par value; 100,000,000 shares authorized, 7,142,307 shares issued and outstanding at June 30, 2012 and December 31, 2011 |
CommonStockValue
|
$7.14K | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapital
|
$71.82M | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapital
|
$70.59M | USD | Point-in-time |
| Accumulated deficit |
RetainedEarningsAccumulatedDeficit
|
$-66.38M | USD | Point-in-time |
| Accumulated deficit |
RetainedEarningsAccumulatedDeficit
|
$-62.30M | USD | Point-in-time |
| Total shareholders equity |
StockholdersEquity
|
$8.30M | USD | Point-in-time |
| Total shareholders equity |
StockholdersEquity
|
$5.45M | USD | Point-in-time |
| Total shareholders equity |
StockholdersEquity
|
$12.79M | USD | Point-in-time |
| Total liabilities and shareholders equity |
LiabilitiesAndStockholdersEquity
|
$5.61M | USD | Point-in-time |
| Total liabilities and shareholders equity |
LiabilitiesAndStockholdersEquity
|
$8.39M | USD | Point-in-time |
Income Statement
49 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Revenue |
SalesRevenueNet
|
$74.12K | USD | 2 Qtrs |
| Revenue |
SalesRevenueNet
|
$137.98K | USD | 1 Quarter |
| Revenue |
SalesRevenueNet
|
$189.57K | USD | 2 Qtrs |
| Revenue |
SalesRevenueNet
|
$70.56K | USD | 1 Quarter |
| Cost of revenues |
CostOfRevenue
|
$36.31K | USD | 1 Quarter |
| Cost of revenues |
CostOfRevenue
|
$25.48K | USD | 2 Qtrs |
| Cost of revenues |
CostOfRevenue
|
$44.01K | USD | 2 Qtrs |
| Cost of revenues |
CostOfRevenue
|
$24.11K | USD | 1 Quarter |
| Gross margin |
GrossProfit
|
$46.45K | USD | 1 Quarter |
| Gross margin |
GrossProfit
|
$101.67K | USD | 1 Quarter |
| Gross margin |
GrossProfit
|
$48.65K | USD | 2 Qtrs |
| Gross margin |
GrossProfit
|
$145.56K | USD | 2 Qtrs |
| Selling, general and administrative expenses |
SellingGeneralAndAdministrativeExpense
|
$1.82M | USD | 2 Qtrs |
| Selling, general and administrative expenses |
SellingGeneralAndAdministrativeExpense
|
$932.23K | USD | 1 Quarter |
| Selling, general and administrative expenses |
SellingGeneralAndAdministrativeExpense
|
$888.80K | USD | 1 Quarter |
| Selling, general and administrative expenses |
SellingGeneralAndAdministrativeExpense
|
$2.45M | USD | 2 Qtrs |
| Research and development |
ResearchAndDevelopmentExpense
|
$2.32M | USD | 2 Qtrs |
| Research and development |
ResearchAndDevelopmentExpense
|
$901.85K | USD | 1 Quarter |
| Research and development |
ResearchAndDevelopmentExpense
|
$2.53M | USD | 2 Qtrs |
| Research and development |
ResearchAndDevelopmentExpense
|
$1.20M | USD | 1 Quarter |
| Operating loss |
OperatingIncomeLoss
|
$-2.04M | USD | 1 Quarter |
| Operating loss |
OperatingIncomeLoss
|
$-4.09M | USD | 2 Qtrs |
| Operating loss |
OperatingIncomeLoss
|
$-4.83M | USD | 2 Qtrs |
| Operating loss |
OperatingIncomeLoss
|
$-1.73M | USD | 1 Quarter |
| Interest income (expense), net |
InterestExpense
|
$-2.83K | USD | 2 Qtrs |
| Interest income (expense), net |
InterestExpense
|
$-1.25K | USD | 1 Quarter |
| Interest income (expense), net |
InterestExpense
|
$-7.44K | USD | 2 Qtrs |
| Interest income (expense), net |
InterestExpense
|
$-3.69K | USD | 1 Quarter |
| Net income (loss) |
NetIncomeLoss
|
$-2.04M | USD | 1 Quarter |
| Net income (loss) |
NetIncomeLoss
|
$-4.08M | USD | 2 Qtrs |
| Net income (loss) |
NetIncomeLoss
|
$-1.73M | USD | 1 Quarter |
| Net income (loss) |
NetIncomeLoss
|
$-8.57M | USD | Annual |
| Net income (loss) |
NetIncomeLoss
|
$-4.82M | USD | 2 Qtrs |
| Net income (loss) - basic (in Dollars per share) |
EarningsPerShareBasic
|
$-0.57 | USD | 2 Qtrs |
| Net income (loss) - basic (in Dollars per share) |
EarningsPerShareBasic
|
$-0.68 | USD | 2 Qtrs |
| Net income (loss) - basic (in Dollars per share) |
EarningsPerShareBasic
|
$-0.29 | USD | 1 Quarter |
| Net income (loss) - basic (in Dollars per share) |
EarningsPerShareBasic
|
$-0.24 | USD | 1 Quarter |
| Net income (loss) - diluted (in Dollars per share) |
EarningsPerShareDiluted
|
$-0.24 | USD | 1 Quarter |
| Net income (loss) - diluted (in Dollars per share) |
EarningsPerShareDiluted
|
$-0.29 | USD | 1 Quarter |
| Net income (loss) - diluted (in Dollars per share) |
EarningsPerShareDiluted
|
$-0.57 | USD | 2 Qtrs |
| Net income (loss) - diluted (in Dollars per share) |
EarningsPerShareDiluted
|
$-0.68 | USD | 2 Qtrs |
| Weighted average number of basic common shares outstanding (in Shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
7.13M | shares | 2 Qtrs |
| Weighted average number of basic common shares outstanding (in Shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
7.14M | shares | 2 Qtrs |
| Weighted average number of basic common shares outstanding (in Shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
7.14M | shares | 1 Quarter |
| Weighted average number of basic common shares outstanding (in Shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
7.14M | shares | 1 Quarter |
| Weighted average number of diluted common shares outstanding (in Shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
7.14M | shares | 1 Quarter |
| Weighted average number of diluted common shares outstanding (in Shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
7.14M | shares | 2 Qtrs |
| Weighted average number of diluted common shares outstanding (in Shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
7.14M | shares | 1 Quarter |
| Weighted average number of diluted common shares outstanding (in Shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
7.13M | shares | 2 Qtrs |
Cash Flow Statement
36 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net loss |
NetIncomeLoss
|
$-2.04M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-4.08M | USD | 2 Qtrs |
| Net loss |
NetIncomeLoss
|
$-1.73M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-8.57M | USD | Annual |
| Net loss |
NetIncomeLoss
|
$-4.82M | USD | 2 Qtrs |
| Depreciation and amortization |
DepreciationAndAmortization
|
$252.98K | USD | 2 Qtrs |
| Depreciation and amortization |
DepreciationAndAmortization
|
$171.51K | USD | 2 Qtrs |
| Stock compensation expense |
ShareBasedCompensation
|
$4.01M | USD | Annual |
| Stock compensation expense |
ShareBasedCompensation
|
$2.83M | USD | 2 Qtrs |
| Stock compensation expense |
ShareBasedCompensation
|
$1.23M | USD | 2 Qtrs |
| Bad debt expense |
ProvisionForDoubtfulAccounts
|
$33.77K | USD | 2 Qtrs |
| (Increase) decrease in accounts receivable |
IncreaseDecreaseInAccountsReceivable
|
$-44.06K | USD | 2 Qtrs |
| (Increase) decrease in accounts receivable |
IncreaseDecreaseInAccountsReceivable
|
$43.25K | USD | 2 Qtrs |
| Increase (decrease) in accounts payable |
IncreaseDecreaseInAccountsPayable
|
$-276.80K | USD | 2 Qtrs |
| Increase (decrease) in accounts payable |
IncreaseDecreaseInAccountsPayable
|
$67.16K | USD | 2 Qtrs |
| Decrease in deferred revenue |
IncreaseDecreaseInDeferredRevenue
|
$-85.91K | USD | 2 Qtrs |
| Net cash used in operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$-2.11M | USD | 2 Qtrs |
| Net cash used in operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$-2.57M | USD | 2 Qtrs |
| Purchase of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$14.07K | USD | 2 Qtrs |
| Purchase of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$1.43M | USD | 2 Qtrs |
| Net cash used in investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-1.43M | USD | 2 Qtrs |
| Net cash used in investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-14.07K | USD | 2 Qtrs |
| Proceeds from exercise of stock options, net |
ProceedsFromStockOptionsExercised
|
$73.14K | USD | 2 Qtrs |
| Net cash provided by financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$73.14K | USD | 2 Qtrs |
| Net decrease in cash and cash equivalents |
CashAndCashEquivalentsPeriodIncreaseDecrease
|
$-3.46M | USD | 2 Qtrs |
| Net decrease in cash and cash equivalents |
CashAndCashEquivalentsPeriodIncreaseDecrease
|
$-2.59M | USD | 2 Qtrs |
| Cash and cash equivalents, beginning of period |
CashAndCashEquivalentsAtCarryingValue
|
$7.22M | USD | Point-in-time |
| Cash and cash equivalents, beginning of period |
CashAndCashEquivalentsAtCarryingValue
|
$13.05M | USD | Point-in-time |
| Cash and cash equivalents, beginning of period |
CashAndCashEquivalentsAtCarryingValue
|
$9.59M | USD | Point-in-time |
| Cash and cash equivalents, beginning of period |
CashAndCashEquivalentsAtCarryingValue
|
$4.63M | USD | Point-in-time |
| Cash and cash equivalents, end of period |
CashAndCashEquivalentsAtCarryingValue
|
$13.05M | USD | Point-in-time |
| Cash and cash equivalents, end of period |
CashAndCashEquivalentsAtCarryingValue
|
$9.59M | USD | Point-in-time |
| Cash and cash equivalents, end of period |
CashAndCashEquivalentsAtCarryingValue
|
$4.63M | USD | Point-in-time |
| Cash and cash equivalents, end of period |
CashAndCashEquivalentsAtCarryingValue
|
$7.22M | USD | Point-in-time |
| Cash paid for interest |
InterestPaid
|
- | USD | 2 Qtrs |
| Cash paid for interest |
InterestPaid
|
- | USD | 2 Qtrs |
Stockholders Equity
16 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Balance |
StockholdersEquity
|
$8.30M | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$5.45M | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$12.79M | USD | Point-in-time |
| Stock compensation expense |
ShareBasedCompensation
|
$4.01M | USD | Annual |
| Stock compensation expense |
ShareBasedCompensation
|
$2.83M | USD | 2 Qtrs |
| Stock compensation expense |
ShareBasedCompensation
|
$1.23M | USD | 2 Qtrs |
| Exercise of stock options |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$73.14K | USD | Annual |
| Exercise of stock options (in Shares) |
StockIssuedDuringPeriodSharesStockOptionsExercised
|
0.00 | shares | 2 Qtrs |
| Net loss |
NetIncomeLoss
|
$-2.04M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-4.08M | USD | 2 Qtrs |
| Net loss |
NetIncomeLoss
|
$-1.73M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-8.57M | USD | Annual |
| Net loss |
NetIncomeLoss
|
$-4.82M | USD | 2 Qtrs |
| Balance |
StockholdersEquity
|
$8.30M | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$5.45M | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$12.79M | USD | Point-in-time |
Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.